Involvement of nicotinergic mechanisms in thyrotropin-releasing hormone-induced neurologic recovery after concussive head injury in the mouse

European Journal of Pharmacology

Volumn 357, Issue 2-3, 1998, Pages 163-169

  Lestage, Pierre ^a   Iris Hugot, Anne ^a   Gandon, Marie Hélène ^a   Lepagnol, Jean ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Mouse; Nicotine; Trauma; TRH (thyrotropin releasing hormone)

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; BRAIN MONOAMINE; FENCLONINE; HEXAMETHONIUM; MECAMYLAMINE; METHYLSCOPOLAMINE; METIROSINE; PROTIRELIN; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CONSCIOUSNESS; CONTROLLED STUDY; DRUG EFFECT; HEAD INJURY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MONOAMINE METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOGENIC MONOAMINES; BRAIN CONCUSSION; CHOLINERGIC ANTAGONISTS; CONSCIOUSNESS; MALE; MICE; MUSCARINIC ANTAGONISTS; PARASYMPATHETIC NERVOUS SYSTEM; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; THYROTROPIN-RELEASING HORMONE; TIME FACTORS;

EID: 0032544774     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00562-7     Document Type: Article

References (54)

1. Abdulla F.A., Calaminici M.-R., Stephenson J.D., Sinden J.D. Unilateral AMPA lesions of nucleus basalis magnocellularis induce a sensorimotor deficit which is differentially altered by arecoline and nicotine. Behav. Brain Res. 60:1994;161-169.
2. Aii H., Koyama M., Kameyama M. Clinical evaluation of thyrotropin-releasing hormone (TRH) in the treatment of spinal cord lesions. Neurol. Med. 25:1986;254-261.
3. Bakay L., Lee J.C., Lee G.C., Peng J.R. Experimental cerebral concussion. J. Neurosurg. 47:1977;525-531.
4. Breese G.R., Cott J.M., Copper B.R., Prange A.J., Lipton M.A., Plotnikoff N.P. Effects of thyrotropin-releasing hormone (TRH) on the action of pentobarbital and other centrally active drugs. J. Pharmacol. Exp. Ther. 193:1975;11-22.
5. Burgus R., Dunn T.F., Desiderio D., Ward D.N., Vale W., Guillemin R. Characterization of ovine hypothalamic hypophysiotropic TSH-releasing factor. Nature. 226:1970;321-325.
6. Cott J.M., Breese G.R., Copper B.R., Barlow T.S., Prange A.J. Investigations into the mechanism of reduction of ethanol sleep by thyrotropin-releasing hormone (TRH). J. Pharmacol. Exp. Ther. 196:1976;594-604.
7. Denny-Brown D. Brain trauma and concussion. Arch. Neurol. 5:1961;1-3.
8. Dilsaver S.C., Majchrzak M.J., Snider R.M., Davidson R.K. A nicotinic receptor antagonist enhances the hypothermic response to a muscarinic agonist. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 15:1991;539-549.
9. Dooley D.J., Bittiger H., Hanser K.L., Bischoff S.F., Waldmeier P.C. Alteration of central α2- and β-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin. Neuroscience. 9:1983;889-898.
10. Faden A.I. Pharmacotherapy in spinal cord injury: a critical review of recent developments. Clin. Neuropharmacol. 10:1987;193-204.
11. Faden A.I. TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies. Brain Res. 486:1989;228-235.
12. Faden A.I., Salzman S. Pharmacological strategies in CNS trauma. Trends Pharmacol. Sci. 13:1992;29-35.
13. Giovannini M.G., Casamenti F., Nistri A., Paoli F., Pepeu G. Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis. Br. J. Pharmacol. 102:1991;363-368.
14. Goldman H., Hodgson V., Morehead M., Hazlett J., Murphy S. Cerebrovascular changes in a rat model of moderate closed-head injury. J. Neurotrauma. 8:1991;129-144.
15. Guidotti A., Cheney D.L., Trabucchi M., Dotevchi M., Wang C.T. Focused microwave radiation: a technique to minimize post-mortem changes of cyclic nucleotides, DOPA and choline and to preserve brain morphology. Neuropharmacology. 13:1974;1115-1122.
16. Hall E.D. High-dose glucocorticoid treatment improves neurological recovery in head-injured mice. J. Neurosurg. 62:1985;882-887.
17. Heal D.J., Stoodley N., Elliott J.M., Marsden C.A., Bennett G.W., Youdim M.B.H. Behavioral and biochemical evidence for the release of noradrenaline in mouse brain by TRH and some of its biologically stable analogs. Neuropharmacology. 26:1987;313-322.
18. Horita A., Carino M.A., Chesnut R.M. Influence of thyrotropin-releasing hormone (TRH) on drug-induced narcosis and hypothermia in rabbits. Psychopharmacology. 49:1976;57-62.
19. Horita A., Carino M.A., Lai H. Pharmacology of thyrotropin-releasing hormone. Annu. Rev. Pharmacol. Toxicol. 26:1986;311-332.
20. Huger F., Patrick G. Effect of concussive head injury on central catecholamine levels and synthesis rates in rat brain regions. J. Neurochem. 33:1979;89-95.
21. Introini I.B., Baratti C.M., Huygens P. Selective brain noradrenaline depletion induced by the neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) does not prevent the memory facilitation induced by a muscarinic agonist in mice. Psychopharmacology. 82:1984;107-112.
22. Jaim-Etcheverry G., Zieher L.M. DSP4, a novel compound with neurotoxic effects on noradrenergic neurons of adult and developing rats. Brain Res. 188:1980;513-523.
23. Jequier F., Lorenberg W., Sjoerdsna K. Tryptophan hydroxylase inhibition: the mechanism by which PCPA depletes brain serotonin. Mol. Pharmacol. 3:1967;274-278.
24. Jones B.E., Bobillier P., Pin C., Jouvet M. The effect of lesions of catecholamine-containing neurons upon monoamine content of the brain and EEG and behavioral waking in the cat. Brain Res. 58:1973;157-177.
25. Jonsson G., Hallman H., Ponzio F., Ross S. DSP4 (N-2(chloroethyl)-N-ethyl-2-bromobenzylamine) - a useful denervation tool for central and peripheral noradrenaline neurons. Eur. J. Pharmacol. 72:1981;173-188.
26. Jouvet M. The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep waking cycle. Ergeb. Physiol. 64:1972;166-307.
27. Kmieciak-Kolada K., Felinska W., Stachura Z., Majchrzak H., Herman Z.S. Concentration of biogenic amines and their metabolites in different parts of brain after experimental cerebral concussion. Pol. J. Pharmacol. Pharm. 39:1987;47-53.
28. Lamour Y., Dutar P., Jobert A. Effects of TRH, cyclo-(His-Pro) and (3-Met-His) TRH on identified septohippocampal neurons in the rat. Brain Res. 331:1985;343-347.
29. Lee E., Desu M. A computer program for computing k samples with right censored data. Comput. Programs Biomed. 2:1972;315-321.
30. Lichtfield J., Wilcoxon F. A simplified method for evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
31. Manaka S., Sano K. Thyrotropin-releasing hormone tartrate (TRH-T) shortens concussion effects following head impact in mice. Neurosci. Lett. 8:1978;255-258.
32. Manaka S., Fuchinone T., Kondoh T., Hori T., Sano K. Effects of thyrotropin-releasing hormone tartrate on consciousness disturbance-preliminary report. Brain Nerve. 29:1977;1075-1081.
33. Marshall L.F., Bruce D.A., Bruno L., Langfitt T.W. Vertebro-basilar spasm: a significant cause of neurological deficit in head injury. J. Neurosurg. 48:1978;56-564.
34. α-((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L- prolinamide monohydrate on the central nervous system in mice and rats. Arzneim.-Forsch. Drug Res. 43:1993;813-817.
35. Mayer G.S., Shoup R.E. Simultaneous multiple electrode liquid chromatographic-electrochemical assay for catecholamines, indolamines and metabolites in brain tissue. J. Chromatogr. 255:1983;533-544.
36. McDonough J.H., Shih T.-M. A study of the N-methyl-D-aspartate antagonistic properties of anticholinergic drugs. Pharmacol. Biochem. Behav. 51:1995;249-253.
37. Miyamoto M., Nagai Y., Narumi S., Saji Y., Nagawa Y. TRH and its novel analog (DN-1417): antipentobarbital action and involvement of cholinergic mechanisms. Pharmacol. Biochem. Behav. 17:1982;797-806.
38. Mushiroi T., Shibahara R., Tamura M., Shimizu T., Itoh Y., Ukai Y., Yoshikuni Y., Kimura K. Montirelin hydrate (NS-3), a TRH analog, improved the disturbance of consciousness caused by head concussion and pentobarbital in mice. Folia Pharmacol. Jpn. 107:1996;237-245.
39. Osterholm J.L., Matthews G.J. Altered norepinephrine metabolism following spinal cord injury: Part I. Relationship to hemorrhagic necrosis and post-wounding neurological deficits. J. Neurosurg. 36:1972;386-394.
40. Osward I. Drugs and sleep. Pharmacol. Rev. 20:1968;273-307.
41. Prange A.J., Wilson I.C., Lara P.P., Alltop L.B., Breese G.R. Effects of thyrotropin-releasing hormone in depression. Lancet. ii:1972;999-1007.
42. Sano K. Clinical studies on thyrotropin releasing hormone tartrate for the treatment of disturbance of consciousness. Adv. Neurol. Sci. 23:1979;184-210.
43. Santori E.M., Schmidt D.E., Kalivas P.W., Horita A. Failure of muscarinic blockage to antagonize analepsis induced by thyrotropin-releasing hormone and MK-771 in the rat. Psychopharmacology. 74:1981;13-16.
44. Schmidt D.E. Effects of thyrotropin-releasing hormone (TRH) on pentobarbital-induced decrease in cholinergic neuronal activity. Psychopharmacol. Commun. 1:1977;469-473.
45. Shrewsbury-Gee J., Lye R.H., Latham A., Slater P. The effects of TRH analogs on cerebral ischaemia produced by middle cerebral artery occlusion in the rat. Exp. Brain Res. 70:1998;342-350.
46. Ushijima I., Yamada K., Furukawa T. Acute and long-term effects of thyrotropin releasing hormone on behavior mediated by dopaminergic and cholinergic activities in mice. Psychopharmacology. 82:1984;301-305.
47. 3H ] norepinephrine by nicotine and potassium chloride from rat brain slices. In: Usdin, E., Synder, S.H. (Eds.), Frontiers in Catecholamines Research. Pergamon, New York, NY, pp. 617-668.
48. Winokur A., Beckman A. Effects of thyrotropin-releasing hormone, norepinephrine and acetylcholine on the activity of neurons in the hypothalamus, septum and cerebral cortex of the rat. Brain Res. 150:1978;205-209.
49. Yamamoto J. Roles of cholinergic, dopaminergic, noradrenergic, serotonergic and GABAergic systems in changes of the EEG power spectra and behavioral states in rabbits. Jpn. J. Pharmacol. 47:1988;123-134.
50. Yamamoto M., Shimizu M. Effects of a new TRH analog, YM-14673 on the central nervous system. Naunyn-Schmiedeberg's Arch. Pharmacol. 336:1987;561-565.
51. Yamamoto M., Shimizu M. Effects of a new analog of thyrotropin-releasing hormone on pentobarbital-induced sleeping time in rodents. Neuropharmacology. 28:1989;863-866.
52. Yarbrough G.G. TRH potentiates excitatory actions of acetylcholine on cerebral cortical neurons. Nature. 263:1976;523-524.
53. Yarbrough G.G. On the pharmacology of thyrotropin releasing hormone (TRH). Prog. Neurobiol. 12:1979;291-312.
54. Yarbrough G.G. Thyrotropin releasing hormone and CNS cholinergic neurons. Life Sci. 33:1983;111-118.